Ujvira 160mg Trastuzumab Emtansine Injection

Ujvira 160mg Trastuzumab Emtansine Injection is a prescription targeted anti-cancer medication used in the treatment of HER2-positive breast cancer. It contains Trastuzumab Emtansine (T-DM1), an antibody-drug conjugate that combines the HER2-targeting properties of trastuzumab with a chemotherapy agent to deliver treatment directly to HER2-positive cancer cells. This targeted approach helps slow the growth and spread of cancer while minimizing damage to healthy tissues. Ujvira 160mg Injection is administered as an intravenous infusion under the supervision of an oncology specialist and is often prescribed for patients who have previously received HER2-targeted therapies. Regular monitoring of liver function, blood cell counts, and heart health is important during treatment to ensure safety and effectiveness. Patients should use Ujvira 160mg Trastuzumab Emtansine Injection only as directed by their healthcare provider.